Asklepios BioPharmaceutical Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Asklepios BioPharmaceutical Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011821
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Asklepios Biopharmaceutical Inc (AskBio) is a biotechnology company that develops and markets novel protein and cellular based therapies. The company has developed library of rAAV biological nano particles that provides unsurpassed transduction. Its products include such as biostrophin, AskBio009, BNP-CHF, BNP-TLE, BNP-FVIII, BNP-RP and BNP-OA. AskBio also offers products for the treatment of muscular dystrophy, hemophilia B, congestive heart failure, epilepsy, hemophilia A, retinitis pigmentos a and osteoarthritis. The company collaborates with corporate, foundation, and academic organizations. It caters to pharmaceutical and biotechnology companies throughout the country. AskBio is headquartered in Chapel Hill, North Carolina, the US.

Asklepios BioPharmaceutical Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Asklepios BioPharmaceutical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Asklepios BioPharma Forms Joint Venture with Columbus Venture 11
Licensing Agreements 12
Calimmune Enters into Licensing Agreement with Asklepios BioPharma 12
Asklepios BioPharma Enters into Licensing Agreement with AveXis 13
Benitec Biopharma Enters into Licensing Agreement with Asklepios BioPharma 14
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology 15
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology 16
Asklepios BioPharma Enters Into Licensing Agreement With REGENX Biosciences For Hemophilia A 17
Acquisition 18
Baxter International Acquires Chatham Therapeutics from Asklepios BioPharma 18
Asklepios BioPharmaceutical Inc – Key Competitors 19
Asklepios BioPharmaceutical Inc – Key Employees 20
Asklepios BioPharmaceutical Inc – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Key Facts 2
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Asklepios BioPharmaceutical Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Asklepios BioPharmaceutical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Asklepios BioPharma Forms Joint Venture with Columbus Venture 11
Calimmune Enters into Licensing Agreement with Asklepios BioPharma 12
Asklepios BioPharma Enters into Licensing Agreement with AveXis 13
Benitec Biopharma Enters into Licensing Agreement with Asklepios BioPharma 14
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology 15
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology 16
Asklepios BioPharma Enters Into Licensing Agreement With REGENX Biosciences For Hemophilia A 17
Baxter International Acquires Chatham Therapeutics from Asklepios BioPharma 18
Asklepios BioPharmaceutical Inc, Key Competitors 19
Asklepios BioPharmaceutical Inc, Key Employees 20

★海外企業調査レポート[Asklepios BioPharmaceutical Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Adimmune Corp (4142):製薬・医療:M&Aディール及び事業提携情報
    Summary Adimmune Corp (Adimmune) is a biopharmaceutical company that manufactures diagnostics, vaccines, and biological products for various diseases. The corporation’s products include tetanus toxoid adsorbed vaccine, influenza vaccine, Japan encephalitis vaccine, and ah1n1 vaccine. It also provide …
  • Jardine Engineering Corporation, Limited:企業の戦略・SWOT・財務分析
    Jardine Engineering Corporation, Limited - Strategy, SWOT and Corporate Finance Report Summary Jardine Engineering Corporation, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Donaldson Co Inc (DCI):企業の財務・戦略的SWOT分析
    Donaldson Co Inc (DCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Leroy Seafood Group ASA:企業の戦略・SWOT・財務情報
    Leroy Seafood Group ASA - Strategy, SWOT and Corporate Finance Report Summary Leroy Seafood Group ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Glythera Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Glythera Ltd (Glythera) is a biotechnology company that focuses on the development of antibody drug conjugates (ADCs) and biotherapeutics for the treatment of cancer. The company develops antibody-based therapies for the treatment of cancer and broader based therapeutics. It uses its proprie …
  • Genera Biosystems Ltd (GBI):企業の財務・戦略的SWOT分析
    Summary Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is …
  • The PNC Financial Services Group Inc:企業のM&A・事業提携・投資動向
    The PNC Financial Services Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The PNC Financial Services Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Entersoft SA (ENTER):企業の財務・戦略的SWOT分析
    Entersoft SA (ENTER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Rallye SA:戦略・SWOT・企業財務分析
    Rallye SA - Strategy, SWOT and Corporate Finance Report Summary Rallye SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Aviragen Therapeutics Inc (AVIR)-医療機器分野:企業M&A・提携分析
    Summary Aviragen Therapeutics Inc (Aviragen) is a pharmaceutical company that carries out anti-infective drug discovery, development and its commercialization to treat respiratory diseases. It has four product candidates in clinical development which address viral infections, namely, vapendavir, ora …
  • Seplat Petroleum Development Company Plc (SEPLAT):企業の財務・戦略的SWOT分析
    Seplat Petroleum Development Company Plc (SEPLAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Yingli Green Energy Holding Company Limited (YGE):電力:M&Aディール及び事業提携情報
    Summary Yingli Green Energy Holding Company Limited (Yingli Solar) is a solar panel manufacturer. It designs, assembles, sells, and installs solar PV systems. It covers the entire value chain of solar PV industry ranging from designing to manufacturing of multicrystalline polysilicon ingots, wafers, …
  • Vision RT Ltd:企業の戦略的SWOT分析
    Vision RT Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Baoding Lightway Green Energy Technology Co Ltd:企業の戦略的SWOT分析
    Baoding Lightway Green Energy Technology Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • IJM Land Berhad:企業の戦略・SWOT・財務情報
    IJM Land Berhad - Strategy, SWOT and Corporate Finance Report Summary IJM Land Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Volt Information Sciences Inc (VOLT):企業の財務・戦略的SWOT分析
    Volt Information Sciences Inc (VOLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Koninklijke Ahold Delhaize N.V.:戦略・SWOT・企業財務分析
    Koninklijke Ahold Delhaize N.V. - Strategy, SWOT and Corporate Finance Report Summary Koninklijke Ahold Delhaize N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • BioSilta Ltd-製薬・医療分野:企業M&A・提携分析
    Summary BioSilta Ltd (Biosilta) is a biotechnology company that develops and markets reagent based microbial growth systems and accessories. The company offers products, which include enpresso growth systems, flasks, plates and seals. Its enpresso growth systems are used in the production of recombi …
  • InvitroCue Ltd (IVQ):製薬・医療:M&Aディール及び事業提携情報
    Summary InvitroCue Ltd (InvitroCue), formerly Bunuru Corporation Ltd, is a provider of bio-analytic solutions. The company provides digital pathology services such as digitization, sample preparation, staining, computer aided diagnosis and consultation, telepathology, automated reporting and image a …
  • 1414 Degrees Ltd (14D):企業の財務・戦略的SWOT分析
    1414 Degrees Ltd (14D) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆